Search Results - "Bäumer, Nicole"
-
1
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer
Published in Clinical cancer research (15-03-2015)“…KRAS mutations are frequent driver mutations in multiple cancers. KRAS mutations also induce anti-EGFR antibody resistance in adenocarcinoma such as colon…”
Get full text
Journal Article -
2
Immunoprotein-Mediated siRNA Delivery
Published in Molecular pharmaceutics (01-05-2017)“…RNA interference strategies offer an alternative to small molecular drug targeting. Small interfering RNA (siRNA) constitutes a class of molecules that allows…”
Get full text
Journal Article -
3
Antibody-coupled siRNA as an efficient method for in vivo mRNA knockdown
Published in Nature protocols (01-01-2016)“…This virus-free approach for mRNA knockdown in vivo uses the siRNA carrier peptide protamine, chemically coupled to a cell surface receptor internalizing…”
Get full text
Journal Article -
4
Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia
Published in International journal of molecular sciences (25-11-2020)“…A microfluidic assay for the detection of promyelocytic leukemia (PML)-retinoic acid receptor α (RARα) fusion protein was developed. This microfluidic-based…”
Get full text
Journal Article -
5
Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth
Published in PloS one (12-07-2018)“…Precision cancer therapy requires on the one hand detailed knowledge about a tumor's driver oncogenes and on the other hand an effective targeted therapy that…”
Get full text
Journal Article -
6
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
Published in Journal of hematology and oncology (01-12-2022)“…Acute myeloid leukemia (AML) is a fatal clonal hematopoietic malignancy, which results from the accumulation of several genetic aberrations in myeloid…”
Get full text
Journal Article -
7
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functions
Published in PloS one (01-04-2014)“…External signals that are mediated by specific receptors determine stem cell fate. The thrombin receptor PAR1 plays an important role in haemostasis,…”
Get full text
Journal Article -
8
Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene
Published in Blood (08-03-2012)“…With the use of ChIP on microarray assays in primary leukemia samples, we report that acute myeloid leukemia (AML) blasts exhibit significant alterations in…”
Get full text
Journal Article -
9
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
Published in Nature cancer (01-05-2021)“…Somatic mutations in DNA methyltransferase 3A (DNMT3A) are among the most frequent alterations in clonal hematopoiesis (CH) and acute myeloid leukemia (AML),…”
Get full text
Journal Article -
10
Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation
Published in PloS one (12-07-2016)“…Intravenous iron supplementation is an effective therapy in iron deficiency anemia (IDA), but controversial in anemia of inflammation (AI). Unbound iron can be…”
Get full text
Journal Article -
11
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
Published in Blood (22-04-2010)“…In a previously developed inducible transgenic mouse model of chronic myeloid leukemia, we now demonstrate that the disease is transplantable using BCR-ABL+…”
Get full text
Journal Article -
12
Retinal pigmented epithelium determination requires the redundant activities of Pax2 and Pax6
Published in Development (Cambridge) (01-07-2003)“…The transcription factors Pax2 and Pax6 are co-expressed in the entire optic vesicle (OV) prior and concomitant with the establishment of distinct…”
Get full text
Journal Article -
13
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML
Published in Experimental hematology (01-09-2015)“…Chromatin-modifying enzymes are frequently altered in acute myeloid leukemia (AML). In the current study, we identified MYST2, a core histone…”
Get full text
Journal Article -
14
Direct and concentration-dependent regulation of the proneural gene Neurogenin2 by Pax6
Published in Development (Cambridge) (15-07-2003)“…Expression of the proneural gene Neurogenin2 is controlled by several enhancer elements, with the E1 element active in restricted progenitor domains in the…”
Get full text
Journal Article -
15
The inhibitor of growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects
Published in PloS one (05-07-2011)“…The proteins of the Inhibitor of Growth (ING) family are involved in multiple cellular functions such as cell cycle regulation, apoptosis, and chromatin…”
Get full text
Journal Article -
16
A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis
Published in PloS one (16-06-2015)“…The quest for novel therapeutic targets in acute myeloid leukemia (AML) is still ongoing. One of such targets, cyclin A1, was shown to be overexpressed in AML…”
Get full text
Journal Article -
17
Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1
Published in PloS one (19-12-2014)“…Functional differences between healthy progenitor and cancer initiating cells may provide unique opportunities for targeted therapy approaches. Hematopoietic…”
Get full text
Journal Article -
18
Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations
Published in American journal of medical genetics. Part C, Seminars in medical genetics (01-12-2023)“…Individuals with Down syndrome (DS) or Autism Spectrum Disorder (ASD), and especially those with both DS and co‐occurring ASD (DS + ASD) commonly display…”
Get full text
Journal Article -
19
DNMT3B Expression Delays Leukemogenesis
Published in Blood (18-11-2011)“…Abstract 3446 Acute myeloid leukaemia (AML) is a malignant disease with poor prognosis, which is, among other biological features, characterized by epigenetic…”
Get full text
Journal Article -
20
Cyclin A1, the alternative A-type cyclin, contributes to G1 S cell cycle progression in somatic cells
Published in Oncogene (14-04-2005)“…Cyclin A1 is an alternative A-type cyclin that is essential for spermatogenesis, but it is also expressed in hematopoietic progenitor cells and in acute…”
Get full text
Journal Article